These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16732341)

  • 1. [Urine peptide patterns in children with milder types of autism].
    Sponheim E; Myhre AM; Reichelt KL; Aalen OO
    Tidsskr Nor Laegeforen; 2006 May; 126(11):1475-7. PubMed ID: 16732341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of urinary opioid peptides in children with autism.
    Cass H; Gringras P; March J; McKendrick I; O'Hare AE; Owen L; Pollin C
    Arch Dis Child; 2008 Sep; 93(9):745-50. PubMed ID: 18337276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Indolyl-3-acryloylglycine (IAG) is a putative diagnostic urinary marker for autism spectrum disorders.
    Bull G; Shattock P; Whiteley P; Anderson R; Groundwater PW; Lough JW; Lees G
    Med Sci Monit; 2003 Oct; 9(10):CR422-5. PubMed ID: 14523330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disembedding performance in children and adolescents with Asperger syndrome or high-functioning autism.
    Kaland N; Mortensen EL; Smith L
    Autism; 2007 Jan; 11(1):81-92. PubMed ID: 17175576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological signs of supplementary-motor-area deficits in high-functioning autism but not Asperger syndrome: an examination of internally cued movement-related potentials.
    Enticott PG; Bradshaw JL; Iansek R; Tonge BJ; Rinehart NJ
    Dev Med Child Neurol; 2009 Oct; 51(10):787-91. PubMed ID: 19416338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation.
    Nelson KB; Grether JK; Croen LA; Dambrosia JM; Dickens BF; Jelliffe LL; Hansen RL; Phillips TM
    Ann Neurol; 2001 May; 49(5):597-606. PubMed ID: 11357950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary compounds in autism.
    Alcorn A; Berney T; Bretherton K; Mills M; Savery D; Shattock P
    J Intellect Disabil Res; 2004 Mar; 48(Pt 3):274-8. PubMed ID: 15025671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders.
    Gabis L; Wei Huang ; Azizian A; DeVincent C; Tudorica A; Kesner-Baruch Y; Roche P; Pomeroy J
    J Child Neurol; 2008 Jul; 23(7):766-74. PubMed ID: 18487520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased excretion of a lipid peroxidation biomarker in autism.
    Ming X; Stein TP; Brimacombe M; Johnson WG; Lambert GH; Wagner GC
    Prostaglandins Leukot Essent Fatty Acids; 2005 Nov; 73(5):379-84. PubMed ID: 16081262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.
    Emanuele E; Colombo R; Martinelli V; Brondino N; Marini M; Boso M; Barale F; Politi P
    Neuro Endocrinol Lett; 2010; 31(1):117-21. PubMed ID: 20150873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct patterns of grey matter abnormality in high-functioning autism and Asperger's syndrome.
    McAlonan GM; Suckling J; Wong N; Cheung V; Lienenkaemper N; Cheung C; Chua SE
    J Child Psychol Psychiatry; 2008 Dec; 49(12):1287-95. PubMed ID: 18673405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linguistic characteristics of individuals with high functioning autism and Asperger syndrome.
    Seung HK
    Clin Linguist Phon; 2007 Apr; 21(4):247-59. PubMed ID: 17453867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Porphyrinuria in childhood autistic disorder: implications for environmental toxicity.
    Nataf R; Skorupka C; Amet L; Lam A; Springbett A; Lathe R
    Toxicol Appl Pharmacol; 2006 Jul; 214(2):99-108. PubMed ID: 16782144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid peptides and dipeptidyl peptidase in autism.
    Hunter LC; O'Hare A; Herron WJ; Fisher LA; Jones GE
    Dev Med Child Neurol; 2003 Feb; 45(2):121-8. PubMed ID: 12578238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlates of head circumference growth in infants later diagnosed with autism spectrum disorders.
    Mraz KD; Green J; Dumont-Mathieu T; Makin S; Fein D
    J Child Neurol; 2007 Jun; 22(6):700-13. PubMed ID: 17641255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromium, cadmium, and lead levels in urine of children with autism and typically developing controls.
    Yorbik O; Kurt I; Haşimi A; Oztürk O
    Biol Trace Elem Res; 2010 Jun; 135(1-3):10-5. PubMed ID: 19688188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data processing in metabolic fingerprinting by CE-UV: application to urine samples from autistic children.
    Soria AC; Wright B; Goodall DM; Wilson J
    Electrophoresis; 2007 Mar; 28(6):950-64. PubMed ID: 17370305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Social and communication development in toddlers with early and later diagnosis of autism spectrum disorders.
    Landa RJ; Holman KC; Garrett-Mayer E
    Arch Gen Psychiatry; 2007 Jul; 64(7):853-64. PubMed ID: 17606819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social maturity and theory of mind in typically developing children and those on the autism spectrum.
    Peterson CC; Slaughter VP; Paynter J
    J Child Psychol Psychiatry; 2007 Dec; 48(12):1243-50. PubMed ID: 18093030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of bipolar disorder comorbidity in adolescents and young adults with high-functioning autism spectrum disorder: a preliminary study of 44 outpatients.
    Munesue T; Ono Y; Mutoh K; Shimoda K; Nakatani H; Kikuchi M
    J Affect Disord; 2008 Dec; 111(2-3):170-5. PubMed ID: 18378000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.